Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study
Piperazine Sulfonamide analogs (1–19) have been synthesized, characterized by different spectroscopic techniques and evaluated for α-amylase Inhibition. Analogs 1–19 exhibited a varying degree of α-amylase inhibitory activity with IC50 values ranging in between 1.571 ± 0.05 to 3.98 ± 0.397 μM when c...
Published in: | European Journal of Medicinal Chemistry |
---|---|
Main Author: | Taha M.; Irshad M.; Imran S.; Chigurupati S.; Selvaraj M.; Rahim F.; Ismail N.H.; Nawaz F.; Khan K.M. |
Format: | Article |
Language: | English |
Published: |
Elsevier Masson s.r.l.
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032929001&doi=10.1016%2fj.ejmech.2017.10.028&partnerID=40&md5=dd50c9fcba76ab67831ba7f3d8094e0c |
Similar Items
-
Synthesis of novel indazole derivatives as inhibitors of diabetics II along with molecular docking and simulation study
by: Al-Nasser F.; Taha M.; Rahim F.; Adalat B.; Chigurupati S.; Nawaz M.; Ajmal A.; Wadood A.; Uddin N.; Khan K.M.; Ali shah S.A.; Felemban S.G.; Venugopal V.
Published: (2025) -
Thiazole based carbohydrazide derivatives as α-amylase inhibitor and their molecular docking study
by: Taha M.; Irshad M.; Imran S.; Rahim F.; Selvaraj M.; Almandil N.B.; Mosaddik A.; Chigurupati S.; Nawaz F.; Ismail N.H.; Ibrahim M.
Published: (2019) -
Synthesis, α-amylase inhibition and molecular docking study of bisindolylmethane sulfonamide derivatives
by: Taha M.; Noreen T.; Imran S.; Nawaz F.; Chigurupati S.; Selvaraj M.; Rahim F.; Hadiani Ismail N.; Kumar A.; Mosaddik A.; Alghamdi A.M.; Abdulrahman nasser alqahtani Y.; Abdulrahman nasser alqahtani A.
Published: (2019) -
Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies
by: Taha M.; Sultan S.; Imran S.; Rahim F.; Zaman K.; Wadood A.; Ur Rehman A.; Uddin N.; Mohammed Khan K.
Published: (2019) -
Synthesis of benzimidazole derivatives as potent inhibitors for α-amylase and their molecular docking study in management of type-II diabetes
by: Hussain S.; Taha M.; Rahim F.; Hayat S.; Zaman K.; Iqbal N.; Selvaraj M.; Sajid M.; Bangesh M.A.; Khan F.; Khan K.M.; Uddin N.; Shah S.A.A.; Ali M.
Published: (2021)